$ANGO 3 SEC Filings

Filed On	Filing
04 Dec 2024	Form 3: Weiss Lawrence T, SVP, Chief Legal Officer No securities owned
21 Jul 2023	Form 3: Burgess Lorinda, Director No securities owned
30 Dec 2021	Form 3: Nighan Warren Jr, SVP Quality and Regulatory Holds 33,879 shares of Common Stock
27 Jul 2021	Form 3: Piccinini Laura, SVP International Holds 10,000 shares of Common Stock
03 Feb 2021	Form 3: Rosenzweig Richard C, SVP and General Counsel No securities owned
16 Sep 2020	Form 3: Tarnoff Michael E, Director No securities owned
14 Sep 2020	Form 3: Centea Scott, SVP/GM, VIT Holds 45,853 shares of Common Stock
19 Jul 2019	Form 3: Licitra Karen A, Director No securities owned
01 Feb 2019	Form 3: Helsel Dave, SVP Global Operations and R&D Holds 14,090 shares of Common Stock
01 Feb 2019	Form 3: Boucher Brent J., SVP and GM of Oncology Holds 14,033 shares of Common Stock
02 Jun 2017	Form 3: Richard Stark, SVP, GM - Oncology Holds 647 shares of Common Stock
25 May 2017	Form 3: Simpson Robert Arthur, SVP/GM, Global Vascular Holds 10,000 shares of Common Stock
25 May 2017	Form 3: Campbell Chad Thomas, SVP/GM, Vascular Access Holds 13,052 shares of Common Stock
09 Nov 2016	Form 3: Auen Eileen O'Shea, Director No securities owned
09 Nov 2016	Form 3: Reed Jan Stern, Director No securities owned
22 Aug 2016	Form 3: Greiner Michael, EVP and CFO No securities owned
05 Apr 2016	Form 3: Clemmer James C, Director No securities owned
10 Nov 2014	Form 3: Trowbridge Stephen A, SVP and General Counsel Holds 25,765 shares of Common Stock
10 Dec 2012	Form 3: Greiner Charles R, VP - Global Franchise Holds 7,512 shares of Common Stock
10 Dec 2012	Form 3: Frost Mark T, Executive Vice President No securities owned

Comments